Skip to main content

Citalopram Hydrobromide

FDA recalls

1 row

DateCompany and reasonClass
Jan 25, 2022Cardinal Healthcare
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II · Terminated

← Back to Citalopram Hydrobromide

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).